This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

Philip Kovach
Senior Scientist, Development Sciences at Avidity Biosciences
Speaker

Profile

Philip Kovach is a Senior Scientist in Pharmacokinetics/Pharmacodynamics at Avidity Biosciences. He holds a Master of Science in Drug Development and Product Management from the UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and has over 12 years of experience advancing antibody oligonucleotide conjugate (AOC) therapies from discovery through clinical development. His work spans bench science, bioanalytical strategy/execution for GLP and clinical studies, and contributions to clinical pharmacology analyses. Philip has supported del-zota (AOC 1044) for Duchenne muscular dystrophy since inception and is a contributing author on related publications and regulatory filings.

Agenda Sessions

  • Advancing RNA Therapeutics: Preclinical Translation of Antibody Oligonucleotide Conjugates (AOC)

    2:15pm